For MERS pneumonia, what is the recommended duration of isolation?

MERS Pneumonia: Isolation Duration

Bold recommendation: Isolate MERS pneumonia patients under airborne and contact precautions until at least 20 days after symptom onset AND until clinical improvement with two consecutive negative lower-respiratory PCRs ≥24 hours apart; extend beyond 20 days if severely ill or immunocompromised. 1, 2

• Rationale and hierarchy of evidence (mortality/morbidity/QOL):
  • Highest-quality, most recent directly relevant data show viable MERS-CoV can persist late:
    • Viable virus cultured on days 18–25 in recovering patients; extensive environmental contamination supports ongoing transmission risk, mandating prolonged isolation and lab-based clearance 1.
    • Replication-competent virus detected up to day 60 in an immunocompromised patient; RNA shedding persisted for 6 months, so symptom resolution alone is unsafe to end isolation in high-risk hosts 2.
  • Systematic comparisons indicate MERS peaks around days 7–10 and can have longer viable shedding than SARS-CoV-2, supporting longer isolation than COVID-19’s symptom-based rules 3.

Practical Algorithm (choose the most stringent applicable box)

• Non-immunocompromised, not critically ill:

  • Maintain airborne + contact + eye protection isolation through:
    • Day 20 after symptom onset, AND
    • Clinical improvement, afebrile, AND
    • Two negative RT-PCRs from lower respiratory tract (e.g., sputum/ET aspirate) ≥24 h apart
  • If lower-tract sampling unavailable, continue isolation until day 20 plus two negative upper-tract PCRs AND low clinical suspicion; consider extending if ongoing cough/sputum.

• Severe/critical illness or immunocompromised (e.g., hematologic malignancy, transplant, high-dose steroids/biologics):

  • Do NOT use time/symptoms alone.
  • Continue isolation until:
    • Clinical improvement, AND
    • Two consecutive negative LOWER-tract PCRs ≥24 h apart.
  • If PCRs remain positive or cannot be obtained reliably, extend isolation up to 60 days or until negative testing, given documented late viable shedding 2. Reassess weekly.

• Healthcare and environment controls (to reduce transmission and protect staff/patients):

  • Airborne isolation room if available; strict surface decontamination—MERS-CoV contaminates high-touch surfaces and adjacent areas; viable virus recovered from fomites and equipment 1.
  • Minimize aerosol-generating procedures; if required, maximal PPE.

Nuances, pitfalls, and how to avoid them

• Pitfall: Ending isolation based on symptoms/time alone (e.g., 10–14 days as for COVID-19). Avoid: Require negative PCRs for MERS, especially lower-tract, due to later viable shedding 1, 3.
• Pitfall: Relying on single negative swab or only oropharyngeal sampling. Avoid: Use two tests ≥24 h apart; prioritize lower-respiratory specimens which better reflect ongoing shedding 1.
• Pitfall: Shortening isolation in immunocompromised hosts. Avoid: Expect prolonged shedding; plan extended isolation until negative tests, as viable virus documented up to day 60 2.
• Facility risk: Environmental contamination persists; ensure rigorous cleaning and dedicated equipment to protect staff and other patients 1.

Contrasting evidence:

• COVID-19 guidelines allow symptom-based discontinuation around day 10–14, but these are not applicable to MERS given later infectious peaks and documented late viable shedding 3. For MERS, lab-based clearance is safer for morbidity/mortality/QOL.